InvestorsHub Logo
Followers 58
Posts 10136
Boards Moderated 1
Alias Born 09/21/2016

Re: Investor2014 post# 134113

Wednesday, 12/13/2017 8:28:21 AM

Wednesday, December 13, 2017 8:28:21 AM

Post# of 461850
from recent 10K...

"

We have filed an investigational new drug application, or IND, for ANAVEX®2-73 for the treatment of Rett syndrome and are currently in preparation for a Phase 2 clinical trial. The IND might not be approved by the FDA, or it may be delayed or put on clinical hold or partial hold, or additional preclinical studies may be required.



As far as we know the 30 day clock has been running since filing.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News